| Literature DB >> 23675805 |
Kenji Hirano1, Masako Ikemura, Suguru Mizuno, Minoru Tada, Hiroyuki Isayama, Takeo Watanabe, Tomotaka Saito, Shuhei Kawahata, Rie Uchino, Tsuyoshi Hamada, Koji Miyabayashi, Takashi Sasaki, Hirofumi Kogure, Natsuyo Yamamoto, Naoki Sasahira, Kazuhiko Koike, Masashi Fukayama, Yasuhiko Sugawara, Norihiro Kokudo.
Abstract
Sclerogenic biliary changes in hepatic amyloidosis are seldom observed. Here, we report two recent cases initially suspected as primary sclerosing cholangitis (PSC), which were later diagnosed as hepatic amyloidosis (AL type). Case 1: On the basis of magnetic resonance cholangiopancreatography (MRCP) findings, PSC was suspected in a 41-year-old woman with jaundice. Computed tomography (CT) showed nodular pulmonary lesions and swollen cervical, mediastinal and para-aortic lymph nodes, the cause of which was unknown despite detailed examinations. Because of rapid deterioration in the patient's liver function, living donor liver transplantation was performed. She was then diagnosed with hepatic amyloidosis, but died of heart failure due to cardiac amyloidosis 74 days after surgery. Case 2: On the basis of MRCP findings, PSC was suspected in a 49-year-old woman with jaundice. CT showed multiple cystic pulmonary lesions, and hypogammaglobulinemia was also observed (immunoglobulin G, 481 mg/dL). After a biliary plastic stent was placed, liver and lung biopsy confirmed the presence of amyloid deposition. These two cases indicate that it is important to consider hepatic amyloidosis as a differential diagnosis of PSC. The presence of atypical extrahepatic lesions may be useful clues for confirming the diagnosis.Entities:
Keywords: amyloidosis; autoimmune pancreatitis; liver biopsy; primary sclerosing cholangitis
Year: 2013 PMID: 23675805 DOI: 10.1111/hepr.12034
Source DB: PubMed Journal: Hepatol Res ISSN: 1386-6346 Impact factor: 4.288